期刊文献+

颈部超声、甲状腺球蛋白诊断复发分化型甲状腺癌 被引量:17

Cervical ultrasound and thyroglobulin in diagnosis of recurrence of differentiated thyroid carcinoma
下载PDF
导出
摘要 背景与目的:颈部超声与血清甲状腺球蛋白(thyroglobulin,Tg)是分化型甲状腺癌(differentiated thyroid carcinoma,DTC)术后随访的主要方法。刺激性Tg对分化型甲状腺癌的诊断价值已被充分证实,但抑制性Tg对DTC复发转移的诊断价值鲜有报道。该研究分析颈部超声及抑制性Tg对DTC复发转移的诊断价值。方法:回顾性分析2010年8月—2014年12月在北京协和医院行2次或以上手术,临床怀疑复发的DTC患者196例。选择其中入院前行甲状腺全切术后和(或)^(131)I清甲治疗术后超声怀疑复发转移的患者共62例。分析转移性淋巴结超声特征以及抑制性Tg对DTC复发转移的诊断价值。结果:经病理证实,62例患者中59例为淋巴结转移,1例为局部复发,2例术后未发现明确复发转移。超声发现可疑淋巴结共121个,经病理证实转移性淋巴结92个,非转移性淋巴结25个,纤维组织3个,横纹肌组织1个。淋巴结内无回声、高回声及强回声对转移性淋巴结的阳性预测值均为100%,皮质内无回声及血流信号杂乱在转移性淋巴结和非转移淋巴结中差异有统计学意义。抑制性Tg阳性者(Tg≥0.2 ng/m L)49例,阴性者(Tg<0.2 ng/m L)13例,抑制性Tg诊断颈部复发转移的准确率为82.3%,灵敏度为81.7%,特异度为100%。结论:皮质内无回声及血流信号杂乱是鉴别复发DTC颈部转移性淋巴结与非转移性淋巴结特异度较高的指标,抑制性Tg(Tg≥0.2 ng/m L)对DTC的复发转移有较高的诊断价值,颈部超声检查可发现血清Tg为阴性患者的复发转移病灶。 Background and purpose: This study investigated the value of cervical ultrasound and TSH-sup- pressed thyroglobulin in the diagnosis of recurrence or metastasis of differentiated thyroid carcinoma (DTC). Methods: This study analyzed the data on 196 thyroid carcinoma patients who underwent neck dissection after clinically sus- pecious recurrence of DTC in Peking Union Medical College Hospital from Aug. 2010 to Dec. 2014. Among the 196 patients, 62 patients sonographically suspecious recurrence after total thyroidectomy and/or radioactive iodine ablation therapy were enrolled in this study. The ultrasonic features of lymph node involvement were retrospectively analyzed, The value of the ultrasonic features in the diagnosis of lymph node involvement and a TSH-suppressed serum Tg level in the diagnosis of recurrence or metastasis of DTC was also evaluated. Results: Of the 62 patients, 59 were pathologi- cally confirmed with lymph node involvement, 1 case with local recurrence and 2 cases without recurrence or metasta-sis. There were 121 ultrasonographically suspected lymph nodes, confirmed by pathology, 92 were metastatic ltsions, 25 were non-metastatic, 3 were fibrous tissue and 1 was striated muscle. The positive predictive rate of cyst, calcification or hyper-echogenicity in cortex was 100% in the diagnosis of lymph node involvement. There was a significant difference in disordered vascularity and cyst in cortex between metastatic and non-metastatic lymph nodes. Forty-nine patients were positive for Tg, whereas 13 were negative. The accuracy, sensitivity and specificity of TSH-suppressed serum Tg in the diagnosis of recurrence or metastasis of DTC were 82.3%, 81.7% and 100%. Conclusion: The disordered vascularity and cyst in cortex of the lymph node are highly specific indexes in diagnosing lymph node involvement. TSH-suppressed serum Tg level has high diagnostic value for detection of recurrence or metastasis of DTC. Cervical ultrasound can identify recurrent or metastatic lesions in both Tg-positive and Tg-negative patients.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2016年第1期97-101,共5页 China Oncology
基金 国家自然科学基金(81541131) 国家国际科技合作专项项目(2015DFA30440)
关键词 分化型甲状腺癌 复发转移 颈部超声 甲状腺球蛋白 Differentiated thyroid carcinoma Recurrence Cervical ultrasound Thyroglobulin
  • 相关文献

参考文献17

  • 1KONDO T, EZZAT S, ASA S L. Pathogenetic mechanisms inthyroid follicular-cell neoplasia[J]. Nat Rev Cancer, 2006,6(4): 292-306.
  • 2HUNDAHL S A, CADY B, CUNNINGHAM M P, et al. Initialresults from a prospective cohort study of 5583 cases of thyroidcarcinoma treated in the United States during 1996. U.S. andGerman Thyroid Cancer Study Group. An American Collegeof Surgeons Commission on Cancer Patient Care EvaluationStudy [J]. Cancer, 2000, 89(1): 202-217.
  • 3DAVID A, BLOTTA A, BONDANELLI M, et al. Serumthyroglobulin concentrations and (131)I whole-body scanresults in patients with differentiated thyroid carcinoma afteradministration of recombinant human thyroid-stimulatinghormone[J]. J Nucl Med, 2001, 42(10): 1470-1475.
  • 4MAZZAFERRI E L, KLOOS R T. Is diagnostic iodine-131scanning with recombinant human TSH useful in the followupof differentiated thyroid cancer after thyroid ablation?[J].J Clin Endocrinol Metab, 2002, 87(4): 1490-1498.
  • 5HAUGEN B R, RIDGWAY E C, MCLAUGHLIN B A, etal. Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant humanthyrotropin[J]. Thyroid, 2002, 12(1): 37-43.
  • 6WARTOFSKY L, rhTSH-STIMULATED THYROGLOBULINSTUDY GROUP. Management of low-risk well-differentiatedthyroid cancer based only on thyroglobulin measurement afterrecombinant human thyrotropin [J]. Thyroid, 2002, 12(7):583-590.
  • 7DUREN M, YAVUZ N, BUKEY Y, et al. Impact of initialsurgical treatment on survival of patients with differentiatedthyroid cancer: experience of an endocrine surgery center inan iodine-deficient region [J]. World J Surg, 2000, 24(11):1290-1294.
  • 8HAUGEN B R M, ALEXANDER E K, BIBLE K C, et al. 2015American Thyroid Association management guidelines foradult patients with thyroid nodules and differentiated thyroidcancer [J]. Thyroid, 2015. [Epub ahead of print].
  • 9G I O V A N E L L A L , C E R I A N I L , S U R I A N O S , e t a l .Thyroglobulin measurement before rhTSH-aided 131I ablationin detecting metastases from differentiated thyroid carcinoma[J]. Clin Endocrinol (Oxf), 2008, 69(4): 659-663.
  • 10SCHLUMBERGER M, HITZEL A, TOUBERT M E, et al.Comparison of seven serum thyroglobulin assays in the followupof papillary and follicular thyroid cancer patients[J]. JClin Endocrinol Metab, 2007, 92(7): 2487-2495.

二级参考文献18

  • 1詹维伟,徐上妍.甲状腺结节超声检查新进展[J].中华医学超声杂志(电子版),2013,10(2):88-93. 被引量:73
  • 2刘跃武,李小毅,高维生.美、英、日三国分化型甲状腺癌手术指南的比较[J].外科理论与实践,2005,10(6):567-568. 被引量:29
  • 3Yasuhiro Ito,Hiroo Masuoka,Mitsuhiro Fukushima,Hiroyuki Inoue,Minoru Kihara,Chisato Tomoda,Takuya Higashiyama,Yuuki Takamura,Kaoru Kobayashi,Akihiro Miya,Akira Miyauchi.Excellent Prognosis of Patients with Solitary T1N0M0 Papillary Thyroid Carcinoma Who Underwent Thyroidectomy and Elective Lymph Node Dissection Without Radioiodine Therapy[J].World Journal of Surgery.2010(6)
  • 4Joseph Kim,Armando E. Giuliano,Roderick R. Turner,Robyn E. Gaffney,Naoyuki Umetani,Minoru Kitago,David Elashoff,Dave S. B. Hoon.Lymphatic Mapping Establishes the Role of BRAF Gene Mutation in Papillary Thyroid Carcinoma[J].Annals of Surgery.2006(5)
  • 5John C. Watkinson.The British Thyroid Association guidelines for the management of thyroid cancer in adults[J].Nuclear Medicine Communications.2004(9)
  • 6Maria A Kouvaraki,Suzanne E Shapiro,Bruno D Fornage,Beth S Edeiken-Monro,Steven I Sherman,Rena Vassilopoulou-Sellin,Jeffrey E Lee,Douglas B Evans.Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer[J].Surgery.2003(6)
  • 7O.Gimm,F. W.Rath,H.Dralle.Pattern of lymph node metastases in papillary thyroid carcinoma[J].Br J Surg.2003(2)
  • 8Coburn M, Teates D, Wanebo HJ. Recurren! Ihyroid cancer. Role of surgery versus radioactive iodine (1131) [J]. Ann Surg, 1994, 219:587-593 ; discussion 593-595.
  • 9Mazzaferri El,, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and lollieular thyroid cancer [J]. Am J Med, 1994, 97: 418-428.
  • 10Schlumberger M J, Torlantano M. Papillary and follicular Ihy- roid carcinoma [ J]. Baillieres Best Pratt Res Clin Endocrinol Metab, 2000, 14: 601-613.

共引文献34

同被引文献114

引证文献17

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部